134 related articles for article (PubMed ID: 21888745)
1. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma.
Mojtahedi Z; Khademi B; Yehya A; Talebi A; Fattahi MJ; Ghaderi A
J Laryngol Otol; 2012 Feb; 126(2):175-9. PubMed ID: 21888745
[TBL] [Abstract][Full Text] [Related]
2. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression.
Mojtahedi Z; Khademi B; Hashemi SB; Abtahi SM; Ghasemi MA; Fattahi MJ; Ghaderi A
Pathol Oncol Res; 2011 Mar; 17(1):7-10. PubMed ID: 20340055
[TBL] [Abstract][Full Text] [Related]
3. NFκB-p50 as a blood based protein marker for early diagnosis and prognosis of head and neck squamous cell carcinoma.
Gupta A; Kumar R; Sahu V; Agnihotri V; Singh AP; Bhasker S; Dey S
Biochem Biophys Res Commun; 2015 Nov; 467(2):248-53. PubMed ID: 26435503
[TBL] [Abstract][Full Text] [Related]
4. Serum level and tissue expression of c-erbB-1 and c-erbB-2 proto-oncogene products in patients with squamous cell carcinoma of the head and neck.
Hoffmann TK; Balló H; Braunstein S; Van Lierop A ; Wagenmann M; Bier H
Oral Oncol; 2001 Jan; 37(1):50-6. PubMed ID: 11120483
[TBL] [Abstract][Full Text] [Related]
5. Circulating fragments of cytokeratin 19 in patients with head and neck squamous cell carcinoma.
Bongers V; Braakhuis BJ; Snow GB
Clin Otolaryngol Allied Sci; 1995 Oct; 20(5):479-82. PubMed ID: 8582085
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of interleukin-6 in patients with primary head and neck squamous cell carcinoma.
Riedel F; Zaiss I; Herzog D; Götte K; Naim R; Hörmann K
Anticancer Res; 2005; 25(4):2761-5. PubMed ID: 16080523
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of serum HMGB1 in diagnosis and prognosis of laryngeal squamous cell carcinoma.
Qiu G; Li Y; Liu Z; Wang M; Ge J; Bai X
Med Oncol; 2014 Dec; 31(12):316. PubMed ID: 25373322
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of altered blood and tissue glutathione levels in head and neck squamous cell carcinoma cases.
Khan SU; Mahjabeen I; Malik FA; Kayani MA
Asian Pac J Cancer Prev; 2014; 15(18):7603-9. PubMed ID: 25292035
[TBL] [Abstract][Full Text] [Related]
9. Investigation of interleukin 10, 12 and 18 levels in patients with head and neck cancer.
Jebreel A; Mistry D; Loke D; Dunn G; Hough V; Oliver K; Stafford N; Greenman J
J Laryngol Otol; 2007 Mar; 121(3):246-52. PubMed ID: 17040593
[TBL] [Abstract][Full Text] [Related]
10. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
11. Serum cytokine profile of laryngeal squamous cell carcinoma patients.
Sotirović J; Perić A; Vojvodić D; Baletić N; Zaletel I; Stanojević I; Erdoglija M; Milojević M
J Laryngol Otol; 2017 May; 131(5):455-461. PubMed ID: 28294085
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of circulating biomarker score in advanced-stage head and neck squamous cell carcinoma.
Park MJ; Roh JL; Kim SB; Choi SH; Nam SY; Kim SY
Eur J Cancer; 2018 Mar; 92():69-76. PubMed ID: 29428866
[TBL] [Abstract][Full Text] [Related]
13. Elevated serum levels of M30 and M65 in patients with locally advanced head and neck tumors.
Ozturk B; Coskun U; Sancak B; Yaman E; Buyukberber S; Benekli M
Int Immunopharmacol; 2009 May; 9(5):645-8. PubMed ID: 19249390
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of TATI and CYFRA 21-1 in patients with head and neck squamous cell carcinoma.
Goumas PD; Mastronikolis NS; Mastorakou AN; Vassilakos PJ; Nikiforidis GC
ORL J Otorhinolaryngol Relat Spec; 1997; 59(2):106-14. PubMed ID: 9166881
[TBL] [Abstract][Full Text] [Related]
15. Diet and proinflammatory cytokine levels in head and neck squamous cell carcinoma.
Arthur AE; Peterson KE; Shen J; Djuric Z; Taylor JM; Hebert JR; Duffy SA; Peterson LA; Bellile EL; Whitfield JR; Chepeha DB; Schipper MJ; Wolf GT; Rozek LS
Cancer; 2014 Sep; 120(17):2704-12. PubMed ID: 24830761
[TBL] [Abstract][Full Text] [Related]
16. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
[TBL] [Abstract][Full Text] [Related]
17. Concomitantly elevated serum matrix metalloproteinases 3 and 9 can predict survival of synchronous squamous cell carcinoma of the upper aero-digestive tract.
Wang WL; Chang WL; Yeh YC; Lee CT; Chang CY; Lin JT; Sheu BS
Mol Carcinog; 2013 Jun; 52(6):438-45. PubMed ID: 22241750
[TBL] [Abstract][Full Text] [Related]
18. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
[TBL] [Abstract][Full Text] [Related]
19. Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck.
Kuropkat C; Lippert BM; Werner JA
Oncology; 2002; 63(3):280-5. PubMed ID: 12381908
[TBL] [Abstract][Full Text] [Related]
20. Association and prognostic value of serum inflammation markers in patients with leukoplakia and oral cavity cancer.
Chang PY; Kuo YB; Wu TL; Liao CT; Sun YC; Yen TC; Chan EC
Clin Chem Lab Med; 2013 Jun; 51(6):1291-300. PubMed ID: 23154424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
